Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Jul 24;14:3501–3521. doi: 10.2147/JIR.S312385

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 Zou et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

Effects of electroacupuncture at the acupoint Feishu (BL13) and Shenshu (BL23) on NLRP3 inflammasome formation and activation induced by PPE instillation. Representative images depict NLPR3 colocalization with (A) ASC or (C) caspase-1. (B and D) Summarized data in the bar graph shows PCC. (E) Representative images depicts IL-1β immunostaining in the lung. (F) Summarized data shows IL-1β levels in different treatment groups. (n=6). *P<0.05 vs PBS treatment. ^#P<0.05 vs PPE treatment group without EA or mice receiving EA at lung-nonspecific acupoint, BL23.